Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vistagen Therapeutics, Inc. - Common Stock (NQ:VTGN)

4.399 +0.149 (+3.52%)
Streaming Delayed Price Updated: 10:48 AM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vistagen Therapeutics, Inc. - Common Stock

News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Vistagen (VTGN) Q2 2026 Earnings Call Transcript ↗
Vistagen (VTGN) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For November 13, 2025 ↗
 
Via Benzinga
News headline image
Examining the Future: VistaGen Therapeutics's Earnings Outlook ↗
 
Via Benzinga
News headline image
Vistagen (VTGN) Q1 R&D Expense Jumps 54% ↗
Via The Motley Fool
News headline image
Earnings Scheduled For August 7, 2025 ↗
 
Via Benzinga
News headline image
Insights into VistaGen Therapeutics's Upcoming Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 13, 2025 ↗
 
Via Benzinga
News headline image
Recap: Vistagen Therapeutics Q3 Earnings ↗
 
Via Benzinga
News headline image
VistaGen Therapeutics's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Insights Ahead: VistaGen Therapeutics's Quarterly Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For June 17, 2025 ↗
 
Via Benzinga
News headline image
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025 ↗
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025. 
Via InvestorPlace
News headline image
3 Stocks Under $15 That Could Make You a Millionaire ↗
Investors looking for millionaire status in the coming years should consider three stocks under $15 that could be worth buying. 
Via InvestorPlace
News headline image
VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024 ↗
VTGN stock results show that VistaGen Therapeutics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024. 
Via InvestorPlace
News headline image
3 Must-Have Penny Stocks to Boost Your 2024 Portfolio ↗
Though volatility remains high, these penny stocks promise significant returns, especially in this high-interest rate economic climate. 
Via InvestorPlace
News headline image
VistaGen Therapeutics Earnings Preview ↗
 
Via Benzinga
News headline image
Meme Stock Rebound: 3 Reddit Favorites Primed for a Resurgence ↗
The internet and forums such as Reddit, are rife with misinformation about stock prospects. However, these three might have potential. 
Via InvestorPlace
News headline image
7 Stocks Under $15 Predicted to Boom in the Next 2 Years ↗
Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy. 
Via InvestorPlace
News headline image
Millionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027 ↗
Explore three stocks under $10 in electronic equipment and instruments, technology hardware, storage and peripherals, and biotechnology. 
Via InvestorPlace
News headline image
Secret Superstars: 3 Unknown Stocks to Turn $5K into $100K by 2027 ↗
Learn the potency of lesser-known stocks and explore their fundamental edge in technology distribution, food retail, and biotechnology. 
Via InvestorPlace
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
3 Revolutionary Biotech Stocks Poised for 10X Surge ↗
Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities. 
Via InvestorPlace
News headline image
3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave ↗
Explore hidden-gem biotech stocks set for growth in a booming market. Uncover top picks ready to redefine healthcare innovation. 
Via InvestorPlace
News headline image
3 Penny Stocks to Buy for the Next Bull Run: February 2024 ↗
As the market pivots in 2024, dive into the dynamic world of penny stocks, revealing the top choices for February's exhilarating bull run. 
Via InvestorPlace
News headline image
3 Penny Stocks to Turn $999 Into $1 Million: January 2024 ↗
With our strengthening economy, you need to invest in penny stocks that will deliver high future returns, these three are your best bets. 
Via InvestorPlace
Topics Economy
News headline image
Undervalued VistaGen Therapeutics, Analyst Highlights Potential In Anxiety Treatment ↗
William Blair initiated coverage on VistaGen Therapeutics Inc (NASDAQ: VTGN), a clinical-stage biopharmaceutical company focused on developing next-generation treatment options for social anxiety... 
Via Benzinga
News headline image
Anxiety-Focused Stock Vistagen Therapeutics Is An Undervalued Late-Stage Neurology Player: Analyst ↗
Analysts at Stifel recently initiated coverage on Vistagen Therapeutics Inc (NASDAQ: VTGN), emphasizing the potential of its lead asset, fasedienol, in clinical development for social anxiety disorder... 
Via Benzinga
News headline image
Earnings Scheduled For February 13, 2024 ↗
Companies Reporting Before The Bell • LCI Indus (NYSE:LCII) is likely to report quarterly earnings at $0.18 per share on revenue of $838.27 million. 
Via Benzinga
News headline image
Earnings Scheduled For November 9, 2023 ↗
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.